• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. OXYSEPT 1-STEP; SOLUTIONS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. OXYSEPT 1-STEP; SOLUTIONS Back to Search Results
Model Number 07167X
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Irritation (1941); Red Eye(s) (2038)
Event Type  Injury  
Manufacturer Narrative
Age/ date of birth: unknown, information not provided.Date of event: exact date unknown, information not provided.Incident date provided only as (b)(6) 2020.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
A consumer reported that his eyes were hurting upon insertion of contact lenses after using oxysept 1-step solution.After removal of the contacts, his eyes were red.The consumer was examined by a physician and was diagnosed with irritated eyes due to using oxysept 1-step solution.The consumer was prescribed an eyedrop medication, name of the medication was not provided.The consumer has used this brand of product for a few years and followed the directions for use.The product was first opened in (b)(6) 2020 and incident date is noted as (b)(6) 2020.Additionally, the consumer has not had lasik surgery, does not have allergies and is not a smoker.The consumer has recovered.No further information has been provided.This report captures the event for the solution.A separate report is being submitted for the neutralizing tablets.
 
Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are nr-0148919 and capa-010215.
 
Manufacturer Narrative
Additional information: section d10: device available for evaluation: yes.Section d10: returned to manufacturer on: 06/14/2020.Section h3: device returned to manufacturer: yes.Device evaluation: one bottle was returned and chemical test was performed.All the testing results were within the product specification, no product deficiency was identified.Manufacturing records review: the manufacturing records for the product was reviewed.The product was manufactured and released according to specification.Complaint data was trended in previous 12 months by the reported lot number: ze07848; search result: only the objective complaint was reported in previous 12 months.Conclusion: as a result of the investigation, there is no indication of a product quality deficiency all pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXYSEPT 1-STEP
Type of Device
SOLUTIONS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key10182415
MDR Text Key200976798
Report Number3004178847-2020-00011
Device Sequence Number1
Product Code LPN
UDI-Public(01)(17)221020(10)ZE07848
Combination Product (y/n)Y
PMA/PMN Number
P850088
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup,Followup
Report Date 01/01/2005,10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/20/2020
Device Model Number07167X
Device Lot NumberZE07848
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/14/2020
Was the Report Sent to FDA? No
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received10/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NEUTRALIZING TABLETS LOT # UNKNOWN
Patient Outcome(s) Required Intervention;
-
-